Core Viewpoint - DocuSign, Inc. is identified as one of the best mid-cap value stocks to buy in 2026, despite a recent price target reduction by UBS from $75 to $54 while maintaining a Neutral rating on the stock [1]. Financial Performance - The company has reported an 8.2% revenue growth over the past 12 months and maintains a profit margin of 79.4% [2]. - The outlook for full-year 2027 indicates a slight revenue deceleration to around 7%, which is below the company's long-term growth target of more than 10% [4]. Market Sentiment - Investor sentiment regarding DocuSign is currently weak, with the market not yet convinced by the company's growth narrative [4]. - The stock is trading at 8 times its calendar year 2026 free cash flow, indicating a cautious approach from investors as they await a rebound in the software application sector [2]. Company Overview - DocuSign provides an electronic signature and digital transaction management platform, enabling businesses to prepare, sign, act on, and manage agreements electronically [5]. - The company leverages AI through its DocuSign Iris engine to enhance its Intelligent Agreement Management (IAM) platform [5].